Colchicine for Autoimmune and Subacute Thyroiditis
Recruiting
Phase 2
Phase 3
Interventional Study
Hashimoto Thyroiditis
Subacute Thyroiditis
Thyroiditis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- Mansoura University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Thyroiditis includes inflammatory thyroid disorders such as Hashimoto's thyroiditis and subacute thyroiditis. These conditions may cause thyroid pain, neck tenderness, elevated inflammatory markers, thyroid dysfunction, fatigue, and recurrence. Current management includes observation, symptomatic treatment, nonsteroidal anti-inflammatory drugs, and corticosteroids. Although corticosteroids may be …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 to 70 years
* Newly diagnosed Hashimoto's thyroiditis or Subacute thyroiditis
* Diagnosis confirmed clinically, biochemically, and ultrasonographically
* Ability to provide written informed consent
Exclusion Criteria:
* Pregnancy or breastfeeding
* Severe renal impair…
Contacts